{"database": "lobbying", "table": "lobbying_activities", "rows": [[794244, "10c785e8-7339-4959-a8e6-772e20d8d3f1", "Q2", "FABIANI & COMPANY", 72576, "ALNYLAM PHARMACEUTICALS", 2009, "second_quarter", "PHA", "S.515 Patent Reform Act\nProvisions relating to the apportionment of damages", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2009-07-16T16:31:58-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["794244"], "units": {}, "query_ms": 17.36880897078663, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}